|Min SIP Amount||₹1000|
|NAV||₹40.65 (23 Oct 2020)|
|Fund Started||07 Jan 2013|
|Fund Size||₹5 Cr|
|Sun Pharmaceutical Inds. Ltd.||Healthcare||Equity||8.0%|
|Bharti Airtel Ltd.||Communication||Equity||7.9%|
|Adani Enterprises Ltd.||Services||Equity||7.2%|
|Ajanta Pharma Ltd.||Healthcare||Equity||7.2%|
|United Spirits Ltd.||FMCG||Equity||6.9%|
|Sumitomo Chemical India Pvt. Ltd.||Others||Equity||6.5%|
|Abbott India Ltd.||Healthcare||Equity||5.4%|
|PI Industries Ltd.||Chemicals||Equity||5.1%|
|Apollo Hospitals Enterprise Ltd.||Healthcare||Equity||4.8%|
|Prestige Estates Projects Ltd.||Construction||Equity||4.3%|
Quant Large and Mid Cap Fund Direct Growth is a Equity Mutual Fund Scheme launched by Quant Mutual Fund. This scheme was made available to investors on 07 Jan 2013. Sanjeev Sharma is the Current Fund Manager of Quant Large and Mid Cap Fund Direct Growth fund.The fund currently has an Asset Under Management(AUM) of ₹5 Cr and the Latest NAV as of 23 Oct 2020 is ₹40.65.
The Quant Large and Mid Cap Fund Direct Growth is rated Moderately High risk. Minimum SIP Investment is set to 1000. Minimum Lumpsum Investment is 5000.
The scheme seeks to provide capital appreciation by investing in a portfolio of Large and Midcap companies.
Returns are taxed at 15%, if you redeem before one year. After 1 year, you are required to pay LTCG tax of 10% on returns of Rs 1 lakh+ in a financial year.